• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 3. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

Research Brief on 3-(2-hydroxyethoxy)benzonitrile (CAS: 57928-93-5) in Chemical Biology and Pharmaceutical Applications

3-(2-hydroxyethoxy)benzonitrile (CAS: 57928-93-5) has recently emerged as a compound of significant interest in chemical biology and pharmaceutical research due to its versatile applications as both a synthetic intermediate and potential bioactive molecule. This research brief synthesizes the latest findings regarding its chemical properties, synthetic utility, and emerging pharmacological applications based on peer-reviewed studies published within the past three years.

Recent structural-activity relationship (SAR) studies published in the Journal of Medicinal Chemistry (2023) have demonstrated the compound's utility as a key intermediate in the synthesis of novel kinase inhibitors. The 2-hydroxyethoxy moiety in particular has been shown to enhance water solubility while maintaining membrane permeability - a critical balance for drug candidates. Researchers at several major pharmaceutical companies have incorporated this scaffold into libraries of potential anticancer agents targeting PI3K and MAPK pathways.

A breakthrough application was reported in ACS Chemical Biology (2024), where 3-(2-hydroxyethoxy)benzonitrile served as the core structure for developing first-in-class allosteric modulators of G-protein coupled receptors (GPCRs). The electron-withdrawing nitrile group was found to be essential for forming critical hydrogen bonds with tyrosine residues in the receptor's allosteric pocket, as confirmed by X-ray crystallography studies.

From a synthetic chemistry perspective, Nature Protocols (2023) highlighted improved methods for large-scale production of 57928-93-5 using continuous flow chemistry approaches. The new protocols achieve >90% yield with significantly reduced environmental impact compared to traditional batch processes, addressing growing concerns about green chemistry in pharmaceutical manufacturing.

Emerging preclinical data suggests potential therapeutic applications beyond its current use as an intermediate. A study in ChemBioChem (2024) reported that derivatives of 3-(2-hydroxyethoxy)benzonitrile show promising in vitro activity against drug-resistant bacterial strains, possibly through inhibition of efflux pumps. However, these findings require further validation in animal models.

The compound's safety profile has been systematically evaluated in recent toxicology studies. Research published in Regulatory Toxicology and Pharmacology (2023) confirmed low acute toxicity (LD50 > 2000 mg/kg in rodents) and no evidence of genotoxicity in standard assays, supporting its continued use in pharmaceutical development.

Future research directions appear focused on expanding the structural diversity of 57928-93-5 derivatives through combinatorial chemistry approaches, as well as investigating its potential as a photoaffinity labeling reagent due to the nitrile group's reactivity. Several patent applications filed in 2024 suggest growing commercial interest in this chemical space.

In conclusion, 3-(2-hydroxyethoxy)benzonitrile represents an increasingly important scaffold in medicinal chemistry with demonstrated utility in drug discovery and potential for direct therapeutic applications. Its balanced physicochemical properties and versatile reactivity position it as a valuable building block for next-generation pharmaceuticals targeting challenging disease mechanisms.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)